Working… Menu
Trial record 10 of 295 for:    IFNA2 AND PEG-interferon alfa-2b

PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00085384
Recruitment Status : Terminated (Terminated due to slow accrual.)
First Posted : June 11, 2004
Last Update Posted : August 2, 2012
National Cancer Institute (NCI)
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : November 2005
Actual Study Completion Date : April 2007